Skip to content

Clinical efficacy study of integrated neuromuscular training for stress urinary incontinence

Clinical efficacy study of integrated neuromuscular training for stress urinary incontinence

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500112028
Enrollment
Unknown
Registered
2025-11-10
Start date
2025-11-17
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stress urinary incontinence

Interventions

Experimental group:Pelvic floor integrative neuromuscular training

Sponsors

Xiangya Third Hospital of Central South University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. It complies with the 2017 edition of the "Guidelines for the Diagnosis and Treatment of Female Stress Urinary Incontinence" issued by the Chinese Medical Association's Obstetrics and Gynecology Society; Mild: Urinary incontinence occurs during coughing and sneezing, and no urine pad is needed; Moderate: Urinary incontinence occurs during daily activities such as running, jumping, and brisk walking, and a urine pad is required; 2. Age 20 to 45 years old, with a history of childbirth; 3. Pelvic floor muscle strength is less than grade 3.

Exclusion criteria

Exclusion criteria: 1. Combine urgent urinary incontinence, overflow urinary incontinence and other types of urinary incontinence; 2. Patients with pelvic organ prolapse (POP-Q > II stage); 3. History of pelvic surgery; 4. Urinary and genital system infections (urinary tract infections, vaginitis, etc.); 5. History of chronic increased abdominal pressure (chronic rhinitis, asthma, constipation, obesity with BMI >= 28 kg/m^2); 6. Recent use of drugs that affect bladder function; 7. Patients who have received pelvic floor rehabilitation treatment within 6 months before enrollment; 8.Patients with mental and neurological disorders who cannot cooperate to complete the treatment.

Design outcomes

Primary

MeasureTime frame
Clinical efficacy ;Pelvic floor function ;Neuro-muscular function ;Quality of Life and Psychological State ;Molecular indicator ;

Countries

china

Contacts

Public ContactLi Xuhong

Xiangya Third Hospital of Central South University

lixh0901@csu.edu.cn+86 137 8712 3704

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026